Table 2.
Feature ID | Description | MS0 | MS6P | MS24P | MS48P | RG0 | RG6P | RG24P | RG48P |
---|---|---|---|---|---|---|---|---|---|
MYB | |||||||||
MDP0000650225 | Transcription factor WER | 6.3 | 2.6 | 1.9 | 2.8 | 0.4 | 0.5 | 1.1 | 0.7 |
MDP0000275800 | Transcription factor MYB44 | 18.7 | 14.1 | 7.1 | 5.5 | 2.7 | 5.4 | 2.7 | 4.7 |
MDP0000149535 | Myb–related protein 306 | 6.8 | 1.3 | 1.5 | 2.0 | 1.1 | 0.3 | 1.4 | 0.9 |
MDP0000165715 | Transcription factor MYB44 | 23.1 | 10.5 | 10.4 | 12.7 | 4.0 | 5.2 | 1.6 | 2.2 |
MDP0000187872 | Transcription factor MYB44 | 17.1 | 6.4 | 7.8 | 12.6 | 3.5 | 14.0 | 5.8 | 4.8 |
MDP0000144744 | Myb–related protein 306 | 37.7 | 16.9 | 24.6 | 23.2 | 12.4 | 9.1 | 1.3 | 0.9 |
MDP0000463846 | Transcription factor MYB44 | 100.2 | 87.8 | 78.2 | 69.1 | 63.6 | 71.3 | 29.5 | 14.6 |
PR–PROTEINS + DISEASE RESISTANCE | |||||||||
MDP0000213440 | Probable protein Pop3 | 4.5 | 2.3 | 3.0 | 1.9 | 0.0 | 0.0 | 0.5 | 0.4 |
MDP0000474349 | Pathogen–related protein | 5.6 | 3.1 | 2.0 | 2.3 | 0.5 | 0.1 | 0.8 | 0.7 |
MDP0000788170 | Pathogen–related protein | 54.6 | 157.3 | 308.1 | 189.5 | 4.9 | 8.6 | 124.4 | 304.8 |
MDP0000686021 | TMV resistance protein N | 5.9 | 6.3 | 2.6 | 1.6 | 0.6 | 11.4 | 3.5 | 1.4 |
MDP0000688401 | Pathogen–related protein | 47.5 | 48.1 | 38.3 | 54.1 | 6.3 | 3.8 | 3.5 | 3.7 |
MDP0000799306 | Pathogen–related protein | 40.3 | 23.7 | 36.7 | 19.0 | 5.7 | 5.1 | 8.6 | 3.7 |
MDP0000253215 | EDS1 (enhanced disease susceptibility 1) | 13.6 | 18.0 | 14.5 | 14.1 | 3.3 | 5.1 | 8.0 | 5.6 |
MDP0000162236 | EDS1 (enhanced disease susceptibility 1) | 27.5 | 87.8 | 25.9 | 21.5 | 13.3 | 38.0 | 33.8 | 20.5 |
MDP0000300756 | Disease resistance protein RPM1 | 7.1 | 4.9 | 4.3 | 2.5 | 26.1 | 21.3 | 4.4 | 2.2 |
MDP0000635659 | Miraculin | 11.3 | 5.7 | 5.8 | 4.9 | 75.4 | 50.9 | 11.2 | 7.3 |
MDP0000245324 | Putative disease resistance protein At4g11170 | 4.4 | 4.6 | 3.7 | 3.3 | 42.9 | 50.9 | 27.1 | 14.1 |
MDP0000255700 | Disease resistance protein RGA2 | 1.1 | 6.1 | 2.0 | 2.0 | 12.5 | 8.7 | 2.6 | 0.9 |
MDP0000125256 | Disease resistance response protein 206 | 3.0 | 255.9 | 116.3 | 45.8 | 36.1 | 95.8 | 173.1 | 96.0 |
MDP0000119071 | Graves disease carrier protein | 2.7 | 0.7 | 2.3 | 1.6 | 33.5 | 3.0 | 2.5 | 1.1 |
MDP0000166759 | Putative disease resistance protein RGA3 | 0.1 | 0.1 | 0.1 | 0.1 | 5.7 | 3.7 | 2.8 | 0.9 |
MDP0000827008 | TMV resistance protein N | 0.2 | 1.3 | 2.3 | 1.6 | 28.1 | 69.6 | 49.7 | 43.5 |
MDP0000640906 | Probable disease resistance protein At5g66900 | 0.0 | 2.9 | 0.2 | 0.5 | 4.2 | 3.0 | 2.3 | 8.4 |
JASMONATE | |||||||||
MDP0000300321 | Lipoxygenase 2 | 15.4 | 3.1 | 6.1 | 5.4 | 0.2 | 0.1 | 1.1 | 1.2 |
MDP0000178268 | Lipoxygenase 2.3 | 295.2 | 167.7 | 229.6 | 121.5 | 7.5 | 8.7 | 10.3 | 8.4 |
MDP0000225501 | Allene oxide synthase | 12.0 | 251.3 | 30.7 | 16.6 | 0.3 | 4.1 | 4.0 | 9.5 |
MDP0000174168 | Lipoxygenase 2 | 16.1 | 10.1 | 16.1 | 10.1 | 0.9 | 1.4 | 4.0 | 3.1 |
MDP0000753547 | Lipoxygenase 2 | 21.2 | 13.1 | 14.9 | 5.9 | 2.0 | 1.7 | 2.4 | 1.1 |
MDP0000274714 | 12–oxophytodienoate reductase 2 | 6.1 | 20.8 | 18.0 | 23.7 | 0.7 | 0.8 | 4.7 | 24.6 |
MDP0000169311 | Lipoxygenase 2.3 | 45.1 | 33.9 | 84.6 | 46.1 | 5.5 | 7.2 | 28.1 | 17.7 |
MDP0000910857 | Allene oxide synthase | 7.0 | 271.6 | 34.3 | 17.8 | 1.0 | 97.1 | 137.8 | 234.1 |
MDP0000198152 | Allene oxide synthase | 12.3 | 3.3 | 8.2 | 4.8 | 3.7 | 1.3 | 1.4 | 0.8 |
MDP0000281525 | Lipoxygenase 2 | 20.2 | 16.7 | 10.4 | 6.9 | 6.3 | 4.1 | 2.4 | 1.2 |
MDP0000150140 | Allene oxide synthase | 26.2 | 20.1 | 12.7 | 10.7 | 8.9 | 7.1 | 8.0 | 2.7 |
MDP0000424398 | Allene oxide synthase | 70.2 | 254.7 | 107.5 | 83.9 | 27.9 | 232.9 | 306.2 | 436.1 |
MDP0000450991 | Lipoxygenase A | 94.3 | 86.5 | 188.5 | 247.6 | 507.9 | 466.5 | 206.6 | 99.6 |
Values represent the gene expression (in RPKM) at time 0 and at 6, 24 and 48 hours after P. expansum inoculation (P). Genes are ordered within each category from lower to higher log2(RG0/MS0).